• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Catalog Number FG540000
Medical Device Problem Code Display or Visual Feedback Problem (1184)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/12/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent an atrioventricular nodal reentrant tachycardia ablation procedure with a carto 3 system and near the end of the procedure a map shift was noted.No error was noted on the carto 3 system.A quadripolar was at the same place of the right atrium (tagged his) since the beginning of the procedure; however, there was a 10mm downward map shift.There was no patient movement, coughing, arm repositioning, or cardioversion prior to noting the map shift.There were no changes to the patient's breathing as well.The procedure was continued to completion since the medical team was finished ablating by the time they noticed the issue.No patient consequences were reported.
 
Additional Manufacturer Narrative
On 1-mar-2026, the product investigation was completed.It was reported that a patient underwent an atrioventricular nodal reentrant tachycardia ablation procedure with a carto 3 system and near the end of the procedure a map shift was noted.No error was noted on the carto 3 system.A quadripolar was at the same place of the right atrium (tagged his) since the beginning of the procedure; however, there was a 10mm downward map shift.There was no patient movement, coughing, arm repositioning, or cardioversion prior to noting the map shift.There were no changes to the patient's breathing as well.The procedure was continued to completion since the medical team was finished ablating by the time they noticed the issue.No patient consequences were reported.Device investigation details: it was reported that during a procedure, a map shift occurred, right at the end of the procedure.There was no harm to the patient, and the medical team managed to finish the procedure with no issues as there was no need to ablate anymore.The manufacturer investigated the issue.The data was requested for investigation, but no data related to the issue was provided.As a result, it was not possible to reproduce or analyze the issue.The root cause of the reported map shift issue was not determined.A manufacturing record evaluation was performed for the carto 3 system # (b)(6), and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO 3 SYSTEM
Common Device Name
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key24272693
Report Number2029046-2026-00391
Device Sequence Number10022289
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public(01)10846835000870(17)200907(10)3035665
Combination Product (Y/N)N
Initial Reporter CountryFR
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/20/2026
Supplement Date Received by Manufacturer03/01/2026
Initial Report FDA Received Date02/05/2026
Supplement Report FDA Received Date03/26/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/07/2020
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-